APA (7th ed.) Citation

ZH, M., XL, L., FH, L., JL, Z., ML, Y., XC, S., . . . WX, G. (2025). Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: A multicenter, propensity score matching analysis. BMC cancer, 25(1), 424. https://doi.org/10.1186/s12885-025-13800-1

Chicago Style (17th ed.) Citation

ZH, Ma, et al. "Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Hepatocellular Carcinoma: A multicenter, Propensity Score Matching Analysis." BMC Cancer 25, no. 1 (2025): 424. https://doi.org/10.1186/s12885-025-13800-1.

MLA (9th ed.) Citation

ZH, Ma, et al. "Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Hepatocellular Carcinoma: A multicenter, Propensity Score Matching Analysis." BMC Cancer, vol. 25, no. 1, 2025, p. 424, https://doi.org/10.1186/s12885-025-13800-1.